?Ulipristal Acetate | USP/EP-Certified Hormone API | ≥99% HPLC?
━━━━━━━━━━━━━━━━━━━━

?Product Overview?

Ulipristal Acetate is a selective progesterone receptor modulator (SPRM) widely utilized in emergency contraception and uterine fibroid management?12. As a high-purity synthetic steroid, it effectively inhibits ovulation and reduces fibroid size by targeting progesterone receptors?34. Compliant with USP/EP standards, it is a critical API for pharmaceutical formulations in gynecology and hormone therapy?15.

?Key Advantages?

? ?≥99% HPLC-Verified Purity?: Ensures optimal bioactivity for clinical efficacy?34.
? ?Stability-Tested?: Maintains potency for 36 months under recommended storage (15-30°C, protected from light)?35.
? ?GMP-Certified Synthesis?: Controlled impurities (<0.3% total) with ISO 9001:2025 compliance?13.

?Applications?

? ?Emergency Contraception?: Key ingredient in oral tablets for post-coital pregnancy prevention?12.
? ?Uterine Fibroid Therapy?: Reduces fibroid volume and menstrual bleeding in long-term treatment?45.
? ?Hormonal Research?: Used in preclinical studies for progesterone receptor modulation?23.

?Quality Certifications?

■ ?USP/EP Monograph Compliance?: Validated residual solvents (e.g., methanol <3000 ppm)?35.
■ ?ISO 17025 Testing?: Batch-specific certificates of analysis (COA) with ≤1.5% variability?13.

?Market Trends?

The global women’s health API market is projected to grow at ?CAGR 7.2% by 2030?, driven by rising demand for non-invasive gynecological treatments?45. Ulipristal Acetate holds ?22% of the SPRM API segment?, with a 25% annual surge in clinical trial demand?13.